Your browser doesn't support javascript.
Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series.
Fu, Dian; Cao, Ruiyuan; Zhao, Lei; Li, Wei; Zhong, Wu; Wen, Jiqiu.
  • Fu D; National Clinical and Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China.
  • Cao R; Wuhan Huoshenshan Hospital, Wuhan, 430100, China.
  • Zhao L; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
  • Li W; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
  • Zhong W; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
  • Wen J; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. zhongwu@bmi.ac.cn.
Crit Care ; 24(1): 578, 2020 09 25.
Article in English | MEDLINE | ID: covidwho-795073
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Pyrazines / Virus Shedding / Coronavirus Infections / Amides Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Crit Care Year: 2020 Document Type: Article Affiliation country: S13054-020-03288-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Pyrazines / Virus Shedding / Coronavirus Infections / Amides Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Crit Care Year: 2020 Document Type: Article Affiliation country: S13054-020-03288-5